Entries by

When Do You Stop Screening for Colorectal Cancer?

Colorectal cancer (CRC) is the third most common cancer in terms of incidence and mortality in both males and females in the U.S. Screening remains the best method to detect the disease early and can reduce the incidence of advanced cancers. Depending on which guidance is followed, average-risk adults should start screening at 45 or […]

,

Aspirin and its Chemopreventive Effect on Colorectal Cancer

Aspirin is a non-steroidal anti-inflammatory drug (NSAIDs) that is commonly used as a pain reliever, antipyretic (fever reducer), and preventative medication for cardiovascular illnesses. It is cost-effective, generic, and available over the counter. Aspirin has also been recommended as being beneficial in preventing the development of colorectal cancer (CRC).  Aspirin has the ability to inhibit […]

What Should Patients Know About Colorectal Cancer Screening? 

March is National Colorectal Cancer Awareness Month—an observance of patients, survivors, caregivers, and advocates to educate their communities about the disease. It is also an opportune time to promote awareness about the importance of screening, prevention, and treatment. The third most common cancer diagnosed in the US, colorectal cancer (CRC) is one of the leading […]

,

Disparity Among Young Colorectal Cancer Patients Seeking Genetic Counseling

Colorectal cancer (CRC) is the leading gastrointestinal neoplasia, which has historically been known to primarily affect individuals over 50 years of age, and screening is currently recommended for those 50 and older. This might soon change to 45 years and older. While CRC incidence has been decreasing among individuals older than 55 years, young-onset CRC […]

Implications of Colorectal Cancer Surgical Outcomes During the Era of COVID-19

The ongoing COVID-19 pandemic has affected elective colorectal cancer (CRC) surgical practices, and its impact on mortality after CRC surgical resections has been slowly emerging.  Early on, studies done in Italy and the United Kingdom presented specific recommendations in hopes of reducing the impact on CRC surgical outcomes, but have yet to conclude which of […]

Benefits of a Shared Decision-Making Tool for Colorectal Cancer Patients

A shared decision-making tool is an approach that allows the clinician to collaborate with the patient in reaching evidence-informed decision making. This tool permits the patient and the physician to work together in order to make health care decisions based on the patient’s preferences and can ultimately strengthen the patient-clinician relationship. It plays a vital […]

Patient Inhibitions A Significant Barrier to Colon Cancer Screening 

Numerous challenges present themselves when a patient chooses to get screened for colorectal cancer (CRC), but we know very little about why patients may opt-out of getting screened.  A survey mailed to 660 patients aged 50-75 years old from the Virginia Ambulatory Care Outcome Research Network practices in June-July 2005 posed an open-ended question regarding […]